Mentor MNT announced Monday that it has agreed to ..... this offer represents a premium of 92% to Mentor 's most recent closing price, we still ..... another firm will attempt to bid higher for Mentor , as it is almost impossible to raise cash
Mentor MNT reported second-quarter results Wednesday ..... firm's breast implant volume. However, Mentor 's underperformance was too subtle to ..... keeping our fair value estimate unchanged. Mentor 's sales totaled $84.5 million in the
Medicis Pharmaceuticals MRX and Mentor Corporation MNT both recently reported progress ..... value estimates for Medicis and Mentor unchanged. After an initial rejection ..... Medicis by a few dollars per share. Mentor is also pursuing the aesthetic
Mentor MNT reported strong fourth-quarter financial ..... Despite lingering economic concerns, Mentor 's breast implant sales totaled $87 million ..... 13%, to $79 million, indicating that Mentor may have gained market share. Fueling
Mentor MNT reported third-quarter results Thursday ..... lower our cash-flow expectations for Mentor during the next year or so. At first glance ..... our fair value estimate significantly. Mentor reported sales of $93 million in the third
Mentor MNT reported second-quarter operating results ..... comfortable with our longer-term projections. Mentor provides breast implants and other aesthetic ..... Unlike with most health-care products, Mentor 's primary value drivers can be affected
After a dismal end to fiscal 2007, Mentor MNT got back on track in the first quarter ..... million. This quarter's results show that Mentor regained momentum in this market after ..... implants slowed uptake in the niche. Mentor solved the study problem by convincing
Mentor MNT announced Thursday that it had reached ..... the needle on our fair value estimate for Mentor . Few details were released about Perouse ..... small manufacturers that competes with Mentor around the world. Unlike in the U.S
full-year breast aesthetic sales will total $250 million to $290 million, which puts the firm about even with competitor Mentor MNT , who appears to have recently lost market share due to poor management of postapproval studies for silicone implants. In
On April 19, Mentor MNT reported preliminary fiscal 2007 operating ..... the firm's underwhelming outlook. Mentor adjusted its 2007 sales guidance to ..... our growth and margin expectations. Mentor appears to have lost market share to